<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian journal of Pediatric Hematology and Oncology</title>
<title_fa>Iranian journal of Pediatric Hematology and Oncology</title_fa>
<short_title>Iran J Ped Hematol Oncol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijpho.ssu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-8892</journal_id_issn>
<journal_id_issn_online>2228-6993</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1402</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2024</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>14</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Complications of total-body irradiation in allogeneic bone marrow transplantation: A review article</title>
	<subject_fa>هماتولوژی</subject_fa>
	<subject>Hematology</subject>
	<content_type_fa>مروری</content_type_fa>
	<content_type>Review</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;border:double windowtext 1.5pt; padding:1.0pt 4.0pt 1.0pt 4.0pt&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span sans-serif=&quot;&quot; style=&quot;font-family:Calibri,&quot;&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; time=&quot;&quot;&gt;Hematopoietic stem cell transplantation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&amp;nbsp;&lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;commonly&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;background:white&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; time=&quot;&quot;&gt;known as&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;bone marrow transplantation (BMT) or allogeneic BMT (&lt;span style=&quot;background:white&quot;&gt;using healthy blood stem cells from a donor)&lt;/span&gt; is the preferred therapeutic option for numerous blood-related conditions, both malignant and non-malignant. It is often the sole therapy strategy and essential for relapsed and refractory hematologic malignancies. There have studies regarding BMT on regimen containing total body irradiation (TBI) and a regimen without TBI. It is expected that TBI-based conditioning regimens provide better antitumor effects than chemotherapy regimens. The primary objective of TBI is to eradicate the recipient&amp;#39;s bone marrow, facilitating the successful engraftment of donor bone marrow. Acute lymphoid leukemia (ALL) is the principal indication for TBI in bone marrow transplantation.&amp;nbsp; Other diseases including Hodgkin&amp;rsquo;s lymphoma, chronic myeloid leukemia (CML), acute myeloid leukemia (AML), multiple myeloma (MM), etc., may benefit from TBI-based regimens; however, TBI use is associated with many side effects.The main complications of patients who underwent TBI-containing conditioning regimens in bone marrow transplantation are vomiting and nausea, with frequencies of approximately 66% and 35%, respectively. However, these events are easily managed. Acute complications include stomatitis, diarrhea, loss of appetite, temporary loss of taste, rash and asthenia. Moreover, veno-occlusive disease, interstitial pneumonitis, lung side effects, growth hormone deficiency, neurological side effects, cataracts, renal toxicity, endocrine impairments, and infertility are other complications in patients who underwent TBI-containing conditioning regimens in bone marrow transplantation. In review article, a complication of total-body irradiation in allogeneic bone marrow transplantation was assessed. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Allogeneic bone marrow transplantation, Complication, Total-body irradiation</keyword>
	<start_page>155</start_page>
	<end_page>163</end_page>
	<web_url>http://ijpho.ssu.ac.ir/browse.php?a_code=A-10-1104-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Kazem</first_name>
	<middle_name></middle_name>
	<last_name>Ansari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>kazzemansarii@gmail.com</email>
	<code></code>
	<orcid>0000-0003-1869-4242</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Shahid sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
	<affiliation_fa>Shahid sadoughi University of Medical Sciences, Yazd, Iran</affiliation_fa>
	 </author>


	<author>
	<first_name>Pouya</first_name>
	<middle_name></middle_name>
	<last_name>Baghi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>pouyabaghiii@gmail.com</email>
	<code></code>
	<orcid>0000-0000-0000-0000</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Urology, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran</affiliation>
	<affiliation_fa>Department of Urology, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran</affiliation_fa>
	 </author>


	<author>
	<first_name>Amer</first_name>
	<middle_name></middle_name>
	<last_name>Yazdanparast</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Aameryazdanparastt@gmail.com</email>
	<code></code>
	<orcid>0000-0000-0000-0000</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pediatrics, Faculty of medicine, Bushehr University of Medical Sciences, Bushehr, Iran</affiliation>
	<affiliation_fa>Department of Pediatrics, Faculty of medicine, Bushehr University of Medical Sciences, Bushehr, Iran</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
